Unichem Labs net loss narrows to Rs 22 crore in September quarter
Unichem Labs had posted a net loss of Rs 41.03 crore for the corresponding period of the previous fiscal, the company said in a filing to the BSE.
New Delhi: Drug firm Unichem Laboratories on Saturday reported a narrowing of its consolidated net loss to Rs 22.20 crore for the quarter ended September 30, 2019.
The company had posted a net loss of Rs 41.03 crore for the corresponding period of the previous fiscal, Unichem Laboratories said in a filing to the BSE.
Its consolidated revenue from operations stood at Rs 295.60 crore for the quarter under consideration. It was Rs 261.15 crore for the same period a year ago, it added.
Unichem Labs manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in several markets across the world. The Company has skills in product development, process chemistry and manufacturing complex API as well as dosage forms.
Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at firstname.lastname@example.org Contact no. 011-43720751 To know about our editorial team click here